Ai întrebări despre autism, ADHD, anxietate sau depresie? Găsești ghiduri clare, verificate de specialiști. Acum, acces gratuit.
Researchers developed a method to identify which genetic networks discovered in model organisms (yeast, neurons, mice) are most relevant to human Parkinson's disease. This translational genetics approach bridges the gap between basic research findings and actual human disease mechanisms.
This cross-sectional study of 80 Parkinson's patients examined relationships between objectively measured daily physical activity (step count) and symptom severity using wearable devices over 6 weeks. Higher daily activity was associated with significantly reduced bradykinesia and paradoxically increased mild dyskinesia, supporting the role of physical activity in managing Parkinson's motor symptoms.
This study investigates the relationship between gray matter volume loss in Parkinson's disease psychosis (PDP) and brain expression of cannabinoid receptor genes, finding a significant association with CB1 but not CB2 receptor expression. The findings suggest the endocannabinoid system may play a role in PDP pathophysiology.
This review examines how wartime conditions—including traumatic brain injury, chronic stress, toxin exposure, and healthcare disruption—influence Parkinson's disease risk and management outcomes. The paper identifies critical gaps in knowledge regarding PD progression in conflict-affected populations and calls for evidence-based humanitarian protocols and telemedicine approaches for neurological care during conflict.
Depression affects over one-third of Parkinson's disease patients with significant diagnostic challenges due to symptom overlap between the conditions. Treatment involves pharmacotherapy (SSRIs, SNRIs, tricyclics) and psychotherapy (CBT, interpersonal therapy) adapted for PD-specific vulnerabilities, though access to specialized mental health care remains limited.
